Sabril Label Expanded for Patients 2 to 10 Years Old
The previously approved therapy is now indicated for treatment in pediatric patients age 2 to 10.
Bcureful and Tuberous Sclerosis Alliance Announce Plans to Combine Efforts
The announcement formally connects Bcureful and the Tuberous Sclerosis Alliance together after working closely together for over the past 8 years.
Important Information About Changes to Access and Availability of Generic Everolimus and Afinitor
The Tuberous Sclerosis Alliance has announced updates to access of everolimus, a drug used to treat several conditions associated with tuberous sclerosis complex.
NDA Green Lighted For Diazepam Buccal Film, Solanezumab and Gantenerumab Fail in Alzheimer Trial, Mind Moments Episode 7 Live
Neurology News Network for the week ending February 15, 2020.
NeurologyLive Friday 5 — February 14, 2020
Take 5 minutes to catch up on NeurologyLive's highlights from the week ending February 14, 2020.
NDA Submitted For CBD in Tuberous Sclerosis Complex, Ataluren Improves Walking Ability in DMD, Lasmiditan Available in Pharmacies
Neurology News Network for the week ending February 8, 2020.
NeurologyLive Friday 5 — February 7, 2020
Take 5 minutes to catch up on NeurologyLive's highlights from the week ending February 7, 2020.
New ICD-10 Codes Added for Dravet Syndrome
The new codes listed by the World Health Organization include changes to Dravet syndrome, status epilepticus, and epilepsy in infants.
Dravet Syndrome Foundation Live Video Education Session
Dravet Syndrome Foundation is pleased to announce a new, live video education session on Thursday, February 13, 2020 at 2pm ET.
Investigational Dyskinesia Treatment Gets FDA Green Light
The FDA has approved the investigational new drug application for AV-101 for the treatment of dyskinesia in patients with Parkinson disease who are treated with levodopa.
2020 Dravet Syndrome Foundation Conference Registration Open
Dravet Syndrome Foundation has announced that registration for this year's DSF Conference is now open.
Phase 3b Trial of Aducanumab, Autoinjector FDA Approved for Fremanezumab, Ticagrelor Phase 3 Trial Announced
Neurology News Network for the week ending February 1, 2020.
NeurologyLive Friday 5 — January 31, 2020
Take 5 minutes to catch up on NeurologyLive's highlights from the week ending January 31, 2020.
NDA Submission for Cataplexy Treatment, Siponimod Approved by EU for Progressive Multiple Sclerosis, RimabotulinumtoxinB Approved for Sialorrhea in Adults
Neurology News Network for the week ending January 27, 2020.
NeurologyLive Friday 5 — January 24, 2020
Take 5 minutes to catch up on NeurologyLive's highlights from the week ending January 24, 2020.
FDA Approves Intranasal Diazepam, Rimegepant and Erenumab Effectively Treats Refractory Migraine, MS Treatments Double Since 2011
Neurology News Network for the week ending January 18, 2020.
NeurologyLive Friday 5 — January 17, 2020
Take 5 minutes to catch up on NeurologyLive's highlights from the week ending January 17, 2020.
New Neuroimaging Guidelines for Migraine, Lemborexant Improves Sleep Onset, Patients with Parkinsons Have Compromised Swimming Ability
Neurology News Network for the week ending January 11, 2020.
Huntington Disease Trial Results; Mind Moments Podcast Now Live; PMM Trial Falls Short
Neurology News Network for the week ending January 4, 2020.
Amylyx Announces ALS Investigational Agent, FDA Approves Golodirsen for DMD, Wave Life Sciences Discontinues Suvodirsen, Discontinuation of Gosuranemab
Neurology News Network for the week ending December 21, 2019.
CBD Reduces Seizures in Tuberous Sclerosis Complex, Fenfluramine Reduces Seizure Frequency While Improving Executive Function, Intranasal Diazepam Effective to Treat Seizures Regardless of Usage Frequency
Neurology News Network for the week ending December 14, 2019.
FDA Grants Breakthrough Designation for RightEye Vision System, Results from ESETT Trial Released, Conference Coverage of the 73rd Annual Meeting of the American Epilepsy Society
Neurology News Network for the week ending December 7, 2019.
Dravet Syndrome Foundation Hosts Research Roundtable at AES 2019
The 10th annual DSF Research Roundtable will take place on Thursday, December 5, in Baltimore, Maryland.
FDA Granted Approval to Cenobamate, Risdiplam is Granted Priority Review Designation, Riluzole Oral Film FDA Approved for Treatment of ALS
Neurology News Network for the week ending November 30, 2019.
Ubrogepant Provides Pain Relief for Acute Migraine, Cenobamate Reduces Focal-onset Seizures, Valbenazine Decreases Involuntary Movements in Patients with Tardive Dyskinesia
Neurology News Network for the week ending November 23, 2019.
Risdiplam Shows Positive Results in SMA, Study Trials for DMD Discontinued, Neflamapimod Granted Fast Track for Treatment of Dementia with Lewy Bodies
Neurology News Network for the week ending November 16, 2019.
Acute Ischemic Stroke Guidelines Updated, Stephen Hahn Nominated for FDA, Satralizumab Reduces Risk of Relapse in NMOSD
Neurology News Network for the week ending November 9, 2019.
Diroximel Fumarate Approved for MS; Personalized Interventions Improve Cognition; Zolgensma Trial Placed on Partial Hold
Neurology News Network for the week ending October 28, 2019.
Aducanumab Reversal Sends Drug to FDA, Cala Trio Reduces Hand Tremor, Ganaxolone Promising in Refractory Status Epilepticus
Neurology News Network for the week ending October 26, 2019.
Lasmiditan Approved for Acute Migraine, Istradefylline Now Available for Parkinson Off Episodes, Omaveloxolone Promising in Friedreich's Ataxia
Neurology News Network for the week ending October 19, 2019.